1. A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Issue 3 (5th December 2014) Authors: Jung, Chang Hee; Park, Cheol‐Young; Ahn, Kyu‐Joeng; Kim, Nan‐Hee; Jang, Hak‐Chul; Lee, Moon‐Kyu; Park, Joong‐Yeol; Chung, Choon‐Hee; Min, Kyung‐Wan; Sung, Yeon‐Ah; Park, Jeong‐Hyun; Kim, Sung Jin; Lee, Hyo Jung; Park, Sung‐Woo Journal: Diabetes/metabolism research and reviews Issue: Volume 31:Issue 3(2015:Mar.) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial*: 达格列净治疗接受二甲双胍治疗失败的亚洲2型糖尿病患者的疗效和安全性:一项随机对照研究. (9th January 2016) Authors: Yang, Wenying; Han, Ping; Min, Kyung‐Wan; Wang, Bei; Mansfield, Traci; T'Joen, Caroline; Iqbal, Nayyar; Johnsson, Eva; Ptaszynska, Agata Journal: Journal of diabetes Issue: Volume 8:Number 6(2016:Nov.) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗